InsiderClue
Insiders · Profile

Fletcher Aaron G.L.

Director at ACTUATE THERAPEUTICS · 10% owner at Lantern Pharma · 10% owner at Azitra · and 3 more. Filing since 24 Jun 2020. CIK 0001789490

ACTU ACTUATE THERAPEUTICS, INC. Director · 3 trades LTRN Lantern Pharma Inc. 10% owner · 16 trades AZTR Azitra, Inc. 10% owner · 2 trades INAB IN8BIO, INC. Director · 6 trades CGTX COGNITION THERAPEUTICS INC Director · 5 trades CUE Cue Biopharma, Inc. Director · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ACTU ACTUATE THERAPEUTICS, INC.
27 Jun 2025
Director
Bought
71,428
$500.00K
57.1%
LTRN Lantern Pharma Inc.
13 Jun 2025
10% owner
Sold at will
40,000
$123.60K
44.5%
LTRN Lantern Pharma Inc.
12 Jun 2025
10% owner
Sold at will
60,647
$204.99K
53.9%
LTRN Lantern Pharma Inc.
11 Jun 2025
10% owner
Sold at will
950
$3.23K
1.7%
LTRN Lantern Pharma Inc.
10 Jun 2025
10% owner
Sold at will
16
$54.40
0.0%
LTRN Lantern Pharma Inc.
29 May 2025
10% owner
Sold at will
20,200
$61.21K
26.9%
LTRN Lantern Pharma Inc.
28 May 2025
10% owner
Sold at will
15,000
$43.05K
21.2%
LTRN Lantern Pharma Inc.
27 May 2025
10% owner
Sold at will
21,037
$64.16K
27.1%
ACTU ACTUATE THERAPEUTICS, INC.
14 Aug 2024
Director
Bought
500,000
$4.00M
65.8%
ACTU ACTUATE THERAPEUTICS, INC.
14 Aug 2024
Director
Sold at will
24,999
$224.99K
16.0%
LTRN Lantern Pharma Inc.
24 May 2024
10% owner
Sold at will
20,000
$126.60K
25.8%
LTRN Lantern Pharma Inc.
23 May 2024
10% owner
Sold at will
10,000
$62.50K
14.4%
LTRN Lantern Pharma Inc.
29 Feb 2024
10% owner
Sold at will
19,703
$95.95K
24.6%
LTRN Lantern Pharma Inc.
28 Feb 2024
10% owner
Sold at will
74,297
$360.34K
54.5%
LTRN Lantern Pharma Inc.
27 Feb 2024
10% owner
Sold at will
50,000
$220.00K
42.0%
LTRN Lantern Pharma Inc.
17 Jan 2024
10% owner
Sold at will
58,889
$247.33K
44.4%
LTRN Lantern Pharma Inc.
29 Nov 2023
10% owner
Sold at will
145,348
$500.00K
40.1%
AZTR Azitra, Inc.
21 Jun 2023
10% owner
Bought
2,297,490
$3.00M
opened
AZTR Azitra, Inc.
21 Jun 2023
10% owner
Sold at will
669,317
no price
100%
INAB IN8BIO, INC.
12 Dec 2022
Director
Bought
75,001
$185.91K
2.1%
CGTX COGNITION THERAPEUTICS INC
28 Nov 2022
Director
Bought
16,064
$42.56K
0.8%
CGTX COGNITION THERAPEUTICS INC
16 Nov 2022
Director
Bought
71,000
$99.40K
3.7%
CGTX COGNITION THERAPEUTICS INC
15 Nov 2022
Director
Bought
1,500,000
$1.80M
329%
LTRN Lantern Pharma Inc.
8 Nov 2022
10% owner
Sold, plan not stated
350,000
$1.54M
83.0%
INAB IN8BIO, INC.
28 Sep 2022
Director
Bought
25,000
$50.54K
0.7%
LTRN Lantern Pharma Inc.
2 Sep 2022
10% owner
Sold, plan not stated
6,445
$33.51K
23.5%
INAB IN8BIO, INC.
29 Aug 2022
Director
Bought
40,000
$80.80K
1.1%
INAB IN8BIO, INC.
26 Aug 2022
Director
Bought
11,214
$22.54K
0.3%
INAB IN8BIO, INC.
17 Aug 2022
Director
Bought
50,000
$96.50K
1.4%
INAB IN8BIO, INC.
16 Aug 2022
Director
Bought
1,773,684
$3.37M
98.5%
CUE Cue Biopharma, Inc.
24 May 2022
Director
Bought
55,000
$183.70K
6.2%
CUE Cue Biopharma, Inc.
23 May 2022
Director
Bought
150,000
$528.00K
20.4%
CUE Cue Biopharma, Inc.
31 Mar 2022
Director
Bought
735,000
$3.50M
opened
CGTX COGNITION THERAPEUTICS INC
13 Oct 2021
Director
Bought
190,000
$2.28M
26.8%
CGTX COGNITION THERAPEUTICS INC
13 Oct 2021
Director
Sold, plan not stated
90
$1.08K
0.0%
CUE Cue Biopharma, Inc.
24 Nov 2020
Director
Bought
6,548
$82.78K
4.1%
CUE Cue Biopharma, Inc.
24 Jun 2020
Director
Bought
7,500
$186.57K
5.0%
37 decisions on file.